Lymphoma is a common disease in companion animals. While conventional chemotherapy has the potential to induce remission and prolong life, relapse is common and novel treatments are needed to improve outcome. This review discusses recent modifications/adjustments to conventional standard of care therapy for canine and feline lymphoma, options for treatment or relapsed/refractory disease, and cutting-edge immunotherapy and small molecule–based approaches that are in varying stages of regulatory approval.

中文翻译：

---

淋巴瘤的新疗法

淋巴瘤是伴侣动物的常见疾病。虽然传统化疗有可能诱导缓解和延长生命，但复发很常见，需要新的治疗方法来改善结果。本综述讨论了最近对犬和猫淋巴瘤常规护理治疗标准的修改/调整、治疗或复发/难治性疾病的选择，以及处于不同监管批准阶段的尖端免疫疗法和基于小分子的方法。